Ateliosis
Ateliosis is a medical condition characterized by a form of dwarfism associated with the deficiency of growth hormone. This condition results in the affected individual having a short stature and delayed physical development, while maintaining normal body proportions.
Etiology[edit]
Ateliosis is primarily caused by a deficiency in the secretion of growth hormone from the pituitary gland. This deficiency can be due to congenital factors, genetic mutations, or acquired conditions that affect the pituitary gland's function.
Clinical Features[edit]
Individuals with ateliosis typically present with:
- Short stature
- Delayed skeletal maturation
- Delayed puberty
- Normal body proportions
Unlike other forms of dwarfism, such as achondroplasia, ateliosis does not involve disproportionate limb growth.
Diagnosis[edit]
The diagnosis of ateliosis involves a combination of clinical evaluation and diagnostic tests, including:
- Measurement of growth hormone levels
- X-rays to assess bone age
- MRI of the pituitary gland
- Genetic testing to identify potential mutations
Treatment[edit]
Treatment for ateliosis often involves hormone replacement therapy. The primary treatment is the administration of synthetic growth hormone to stimulate growth and development. Early diagnosis and treatment are crucial for achieving optimal outcomes.
Prognosis[edit]
The prognosis for individuals with ateliosis varies depending on the severity of the growth hormone deficiency and the timing of treatment initiation. With appropriate treatment, many individuals can achieve near-normal height and development.
See Also[edit]
References[edit]
External Links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian